IGZO thin film-based 2*3 transistor array device and preparation method and application thereof
By combining β2-MG and CysC antibodies with β2-MG and CysC antibodies, the problems of difficulty in preparing traditional biosensor devices and the limitation of single biomolecule recognition are solved, and high sensitivity detection of β2-MG and CysC proteins are achieved. Meets the needs of medical testing.
Patent Information
- Application Number
- CN202411176713.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-12-03
AI Technical Summary
Existing laboratory-made biosensor devices cannot be prepared in large quantities, have poor stability, and cannot meet the needs of medical testing, and single biomolecule recognition limits the ability to identify complex samples.
Develop a 2×3 transistor array device based on IGZO film, combining β2-MG and CysC antibodies, and combining with IGZO films through APTES-GA chemical bonds to achieve high sensitivity detection of β2-MG and CysC proteins, and is prepared by standard micro-nano technology. It includes an Al2O3 dielectric layer and an IGZO channel layer to form a 2×3 transistor array.
The simultaneous high-throughput specific sensitive detection of β2-MG and CysC proteins is achieved, with detection limits of 1.2×10-5μg/mL and 4.0×10-6μg/mL, respectively, which improves the sensitivity and detection accuracy of the sensor and reduces the The cost of testing is applicable to early diagnosis and prognosis monitoring of a variety of elderly diseases.
Smart Images

Figure CN119064593A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biosensing, new functional materials and micro-nano technology, and specifically relates to a 2×3 transistor array device based on an IGZO film, a preparation method and an application thereof. Background Art
[0002] With the growth and aging of the population, people's demand for medical services continues to increase, which leads to increasingly tight medical resources. Traditional detection methods cannot meet the medical needs of modern people. Therefore, the development of highly sensitive, convenient, intelligent and multifunctional detection equipment is one of the important directions for the development of medical detection in the future. Biosensors provide a fast and simple new method for medical detection due to their specificity, sensitivity and fast response. The research background of biosensors in medical detection involves the use of specific molecules or biochemical reactions in organisms as signals to detect diseases or monitor health status. These sensors can detect biomarkers in the blood, such as proteins, genes or metabolites, to provide a means of early disease diagnosis and treatment monitoring. However, many sensors prepared in the laboratory have problems such as the inability to prepare devices in large quantities and poor device stability, and cannot be widely used. In view of the above problems, the development of biosensor devices that are compatible with standard micro-nano processes, easy to miniaturize, and have high detection sensitivity is more in line with the needs of the development of medical detection equipment in the future.
[0003] Transistors prepared based on micro-nano technology meet the above requirements. Transistors can adjust the current through gate voltage, which makes them highly sensitive when detecting biological molecules or biological reactions and can provide accurate measurement results. The use of micro-nano technology can accurately control the size of transistors, low power consumption, fast response and good integration, making metal-oxide-semiconductor field-effect transistors one of the most popular technologies in the field of biosensors. Transistor devices with IGZO thin films as channels have attracted widespread attention from researchers due to their high electron mobility, good chemical stability, low power consumption and flexible preparation. At present, many studies have constructed a variety of transistor biosensors based on IGZO thin films and achieved sensitive detection of a variety of disease markers.
[0004] In addition to the excellent performance of IGZO-based transistors in preparation, the biofunctionalization step is also crucial, and the selection of appropriate biorecognition molecules for device functionalization is essential. Currently, biosensors used in disease diagnosis are basically functionalized using single biomolecules that have specific recognition effects on disease markers, which may limit the device's recognition of complex samples. The use of a combination of multiple markers is a way to solve this specific limitation. β2-microglobulin is a low molecular weight serum globulin produced by lymphocytes, platelets, and polymorphonuclear leukocytes, and exists on the surface of various cells outside mature red blood cells and placental trophoblast cells. β2-MG is a sensitive indicator of impaired renal function in hypertension and diabetes, and is related to a variety of elderly diseases. Cystatin C is a type of cysteine protease inhibitor protein present in human body fluids. The detection of cystatin C is of great significance for the judgment of early kidney damage and the diagnosis of its diseases. Therefore, the combination of β2-MG and CysC as a detection marker is of great significance for the early diagnosis and prognosis monitoring of a variety of elderly diseases, especially chronic kidney disease. Summary of the invention
[0005] The present invention is based on the above background technology and aims to provide a 2×3 transistor array device based on IGZO thin film and a preparation method and application thereof.
[0006] The present invention provides a 2×3 transistor array device based on IGZO thin film, which is used for simultaneously detecting β2-MG and CysC, and has the following characteristics, including: a substrate; a dielectric layer, which is arranged on the substrate and is made of Al2O3; at least one transistor array, the transistor array including: 6 channel layers made of IGZO material, which are distributed on the dielectric layer and do not contact each other, 6 pairs of source electrodes and drain electrodes, which are arranged in pairs on the dielectric layer and are indirectly connected through the corresponding channel layers, and a gate electrode, which is arranged on the substrate and contacts the dielectric layer; a sample plate, which is arranged A plurality of sample grooves with openings facing upward are provided on the sample plate above the dielectric layer and the transistor array, the sample grooves correspond to the channel layers one by one and are connected to the surface of the channel layers; and β2-MG antibody and CysC antibody are bound to the channel layers and located in the sample grooves, wherein in a single transistor array, at least one channel layer is bound to the β2-MG antibody, and at least one channel layer is bound to the CysC antibody, and the detection limits of the 2×3 transistor array device based on the IGZO film for the β2-MG antigen protein and the CysC antigen protein are 1.2×10 -5 μg / mL and 4.0×10 -6 μg / mL.
[0007] The 2×3 transistor array device based on IGZO thin film provided by the present invention may also have the following characteristics: in a single transistor array, β2-MG antibody is bound to three channel layers, and CysC antibody is bound to the other three channel layers.
[0008] The 2×3 transistor array device based on the IGZO thin film provided by the present invention may also have the following characteristics: wherein the material of the substrate includes p ++ -Si, the material of the source, drain or gate includes Cr and / or Au, and the material of the sample plate includes transparent PDMS.
[0009] The 2×3 transistor array device based on the IGZO thin film provided by the present invention may also have the following feature: wherein the source and the drain are both connected to the channel layer through leads of an integrally formed design.
[0010] The present invention provides a method for preparing a 2×3 transistor array device based on an IGZO film, which has the following characteristics and is used to prepare any of the above-mentioned 2×3 transistor array devices based on an IGZO film, comprising the following steps: S10, depositing a layer of Al2O3 film as a dielectric layer on a clean substrate, and then depositing a layer of IGZO film as a channel layer at several different positions on the dielectric layer; S20, etching part of the dielectric layer in a preset area to reach the substrate surface; S30, depositing a source electrode and a drain electrode correspondingly at several channel layers on the dielectric layer, and depositing a gate electrode at the area etched in step S20; S40, placing a sample plate with a sample groove on the dielectric layer deposited with the source electrode and the drain electrode, and making the sample groove correspond to the channel layer one by one; S50, respectively binding β2-MG antibody and CysC antibody to the channel layers in several different sample grooves through APTES-GA.
[0011] In the preparation method of the 2×3 transistor array device based on IGZO film provided by the present invention, it can also have the following characteristics: wherein, step S10 includes the following sub-steps: S11, preparing a layer of Al2O3 film as a dielectric layer on the surface of a clean substrate by atomic energy deposition; S12, preparing a layer of IGZO film by deposition on the surface of the dielectric layer by magnetron sputtering, and then spin-coating photoresist in a set area on the film and performing ultraviolet exposure, development and fixing to achieve IGZO patterning; S13, using an acid solution to wet-etch the IGZO film on the part where the photoresist is not spin-coated, and the remaining part is a number of channel layers.
[0012] In the preparation method of the 2×3 transistor array device based on IGZO film provided by the present invention, it can also have the following characteristics: wherein, step S20 includes the following sub-steps: S21, spin-coating photoresist on a part of the set area of the dielectric layer and the channel layer and etching out the set gate area through a UV lithography process; S22, using a mixture of monohydrated ammonia, hydrogen peroxide and water as an etching solution to etch away the Al2O3 film corresponding to the set gate area and pass to the upper surface of the substrate.
[0013] In the preparation method of the 2×3 transistor array device based on IGZO film provided by the present invention, it can also have the following characteristics: wherein, step S30 includes the following sub-steps: S31, spin-coating photoresist on the dielectric layer and the channel layer and etching the set source region and drain region through ultraviolet lithography process, and depositing Cr and / or Au on the source region, the drain region, the area etched in step S20 and the photoresist through PVD; S32, stripping the photoresist and the Cr and / or Au covering the photoresist in an acetone solution, and the remaining parts are the source, the drain and the gate.
[0014] In the preparation method of the 2×3 transistor array device based on IGZO film provided by the present invention, it can also have the following characteristics: wherein, step S40 includes the following sub-steps: S41, mixing PDMS and a coagulant and pouring them into a mold of a set shape and heating and curing them to obtain a sample plate, S42, setting the sample plate on the dielectric layer treated in step S30 through the adhesion of PDMS; step S50 includes the following sub-steps: S51, pouring a 1% APTES ethanol solution into several sample grooves and completely covering the channel layer in the sample groove area, incubating for a certain time, and washing away the unbound APTES with ethanol, S52, heating the device treated in step S51, adding a 2.5% GA solution to the sample groove and incubating for a certain time, and then washing away the unbound GA with PBS, S53, adding β2-MG antibody and CysC antibody to the corresponding sample grooves respectively and incubating for a certain time, and then washing away the unbound β2-MG antibody and CysC antibody with PBS.
[0015] The present invention also uses any of the aforementioned 2×3 transistor array devices based on IGZO thin film, and provides an application of a 2×3 transistor array device based on IGZO thin film in simultaneous high-throughput specific and sensitive detection of microliter-level β2-MG antigen protein and CysC antigen protein.
[0016] Functions and Effects of the Invention
[0017] The present invention provides a β2-MG antibody and CysC antibody functionalized transistor sensor device for detecting β2 microglobulin and cystatin C. The β2-MG antibody and CysC antibody biorecognition molecules are organically combined with the IGZO film through APTES-GA, that is, APTES and GA react to form a stable chemical bond, which helps the two antibodies to exist on the IGZO surface for a long time. By optimizing the antibody concentration, enough antibody molecules are firmly attached to the IGZO surface, providing abundant binding sites for the target molecules, which is beneficial to improve the sensitivity of the sensor. Compared with the currently available clinical enzyme-linked immunosorbent assay (ELISA) and other methods, the sensor has a wider detection range for β2-MG and CysC proteins, and the detection limits for β2-MG and CysC proteins are 1.2×10 -5 μg / mL and 4.0×10 -6 μg / mL, and can realize direct detection of liquid samples.
[0018] The IGZO-based transistor array device prepared in the present invention uses Al2O3 thin film as the dielectric layer. Compared with the traditional IGZO-based transistor device prepared with SiO2 as the dielectric layer, the device prepared with this dielectric layer has a lower threshold voltage and a higher electron mobility, which can significantly improve the performance of the transistor.
[0019] The chip prepared in the present invention is a 2×3 arrayed device, and the 6 detection units contained in each device have good consistency, avoiding the performance error caused by the process preparation process of a single detection unit, making the detection effect more accurate. The arrayed IGZO-based transistor biosensor device can realize the simultaneous detection of β2-MG protein and CysC protein, with low detection cost, and has broad application prospects in high-throughput sensitive detection of disease markers. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1 is a front cross-sectional view of a partial structure of a 2×3 transistor array device based on an IGZO thin film according to an embodiment of the present invention;
[0021] Figure 2 is a complete top view of a 2×3 transistor array device based on an IGZO thin film according to an embodiment of the present invention;
[0022] Figure 3 is a schematic structural diagram of a transistor array according to an embodiment of the present invention;
[0023] Figure 4 It is a schematic flow chart of a method for preparing a 2×3 transistor array device based on an IGZO thin film according to an embodiment of the present invention;
[0024] Figure 5 It is a schematic diagram of a biofunctionalization process of a 2×3 transistor array device based on an IGZO thin film according to an embodiment of the present invention;
[0025] Figure 6 is a SEM characterization image of a partial cross section of a 2×3 transistor array device based on an IGZO thin film according to a test example of the present invention;
[0026] Figure 7 is an optical microscope image of a partial cross section of a 2×3 transistor array device based on an IGZO thin film according to a test example of the present invention;
[0027] Figure 8 is an AFM characterization image of a partial cross section of a 2×3 transistor array device based on an IGZO thin film according to a test example of the present invention;
[0028] Fig. 9 is a transfer characteristic curve of a 2×3 transistor array device based on an IGZO thin film according to a test example of the present invention;
[0029] Fig.10 It is a transfer characteristic curve of a 2×3 transistor array device based on an IGZO thin film in a test example of the present invention when the dielectric layer material is replaced from Al2O3 to SiO2;
[0030] Fig.11 It is a performance consistency test of six channel layers and antibodies bound thereto in a single transistor array in a 2×3 transistor array device based on IGZO thin film of the test example of the present invention;
[0031] Fig.12 This is a biosensing performance test diagram of a 2×3 transistor array device based on an IGZO thin film according to a test example of the present invention;
[0032] Fig.13 It is a detection specificity test diagram of a 2×3 transistor array device based on an IGZO thin film according to a test example of the present invention. DETAILED DESCRIPTION
[0033] In order to make the technical means, creative features, objectives and effects achieved by the present invention easy to understand, the following embodiments and drawings specifically illustrate a 2×3 transistor array device based on IGZO thin film and its preparation method and application.
[0034] <Example>
[0035] Figure 1 It is a front cross-sectional view of a partial structure of a 2×3 transistor array device based on an IGZO thin film according to an embodiment of the present invention.
[0036] like Figure 1 As shown, this embodiment provides a 2×3 transistor array device 100 based on an IGZO thin film, including a substrate 10 , a dielectric layer 20 , a transistor array 30 , a sample plate 40 and an antibody 50 .
[0037] The substrate 10 is p ++ -Si substrate. Specifically, in this embodiment, it is a clean silicon wafer.
[0038] The dielectric layer 20 is a 30 nm thick Al 2 O 3 film covering the substrate 10 .
[0039] Figure 2 It is a complete top view of a 2×3 transistor array device based on an IGZO thin film according to an embodiment of the present invention.
[0040] like Figure 1 and 2 As shown, the number of transistor arrays 30 is 9, and the 9 transistor arrays 30 are distributed on the dielectric layer 20 in a 3×3 pattern.
[0041] Figure 3 Schematic diagram of the structure of a transistor array according to an embodiment of the present invention.
[0042] like Figure 3 As shown, the transistor array 30 includes a channel layer 31 , a source S, a drain D and a gate G.
[0043] like Figures 1 to 3 As shown, the channel layer 31 is six IGZO thin films with a thickness of 30 nm and a size of 40 μm×180 μm covering six different regions on the dielectric layer 20 , and the six channel layers 31 are not in contact with each other. Specifically, in this embodiment, the six channel layers 31 are arranged in two columns and three rows.
[0044] The number of source electrodes S and drain electrodes D are both 6, and the size of each is 500 μm×500 μm. The two are arranged in pairs and correspond to the channel layer 31 one by one and are respectively connected to the channel layer 31 through 100 μm wide leads.
[0045] Among them, the two leads of the source S and the drain D respectively connected to the channel layer 31 are not in direct contact with each other, and there is a certain space between the two above the channel layer 31, which is recorded as the channel. The lengths of the channels on the three channel layers 31 in a single column are 10μm, 15μm and 20μm respectively.
[0046] In a single transistor array 30 , six pairs of source electrodes S and drain electrodes D are connected to a total of 12 different extraction electrodes Pad having a size of 0.6 mm×2 mm through wires having a width of 100 μm.
[0047] The gate G is disposed on the substrate 10 and in contact with the dielectric layer 20. Specifically, the size of the gate G in this embodiment is 0.6 mm×2 mm. The gate G and the 12 lead electrodes Pad are disposed in a row and parallel to each other.
[0048] Specifically, the source electrode S, the drain electrode D, the gate electrode G, the lead wire and the lead-out electrode Pad are all 10 nm thick Cr and 30 nm thick Au arranged layer by layer.
[0049] The sample plate 40 is made of transparent PDMS and is disposed on the dielectric layer 20 and the transistor array 30 . A total of 54 sample grooves 40 a with openings facing upward are formed thereon in an arrangement of 2×3×9. The bottoms of several sample grooves 40 a correspond one-to-one with the channel layer 31 and are connected to the surface of the channel layer 31 .
[0050] Antibodies 50 include β2-MG antibody and CysC antibody.
[0051] Both the β2-MG antibody and the CysC antibody are bound to the channel layer 31 and are located in the sample slot 40a. In a single transistor array 30, the β2-MG antibody is bound to the 3 channel layers 31 in the left column of the 6 channel layers 31 arranged in 2 columns and 3 rows, and the CysC antibody is bound to the 3 channel layers 31 in the right column.
[0052] Figure 4 It is a schematic flow chart of a method for preparing a 2×3 transistor array device based on an IGZO thin film according to an embodiment of the present invention.
[0053] like Figure 4 As shown, this embodiment provides a method for preparing a 2×3 transistor array device based on an IGZO thin film, which is used to prepare a 2×3 transistor array device 100 based on an IGZO thin film provided in this embodiment. The method adopts a standard micro-nano process to prepare a transistor. The process sequence mainly includes multiple key processes such as Al2O3 thin film deposition, IGZO deposition, photolithography, etching, degumming, overlaying, chromium / gold (Cr / Au) electrode deposition, lift-off, and PDMS sample groove preparation. Specifically, the following steps are included:
[0054] S10, preparing a dielectric layer 20 and a channel layer 31 on a substrate 10, specifically comprising the following sub-steps:
[0055] S11, cleaning the silicon wafer according to a standard process, and drying it with a nitrogen gun to prepare it as a substrate 10, and then preparing a layer of Al2O3 film as a dielectric layer 20 on the surface of the clean substrate 10 by atomic energy deposition (ALD, TFS-200, BENEQ);
[0056] S12, depositing a layer of IGZO thin film on the surface of the dielectric layer 20 by magnetron sputtering, then spin-coating photoresist on the IGZO thin film using a photolithography mask of a set shape and performing ultraviolet exposure, development and fixing;
[0057] S13 , using 1:500 diluted hydrochloric acid to wet-etch the IGZO film in the portion not blocked by the photoresist, and the remaining portion is a plurality of channel layers 31 .
[0058] S20, etching a portion of the dielectric layer 20 in a preset area to the substrate surface (for subsequent gate deposition), specifically including the following sub-steps:
[0059] S21, spin-coating photoresist on a part of the set area of the dielectric layer 20 and the channel layer 31 and etching a set gate area by ultraviolet lithography;
[0060] S22 , using a mixture of monohydrated ammonia, hydrogen peroxide and water in a ratio of 1:1:3 as an etching solution to etch the Al 2 O 3 film in the unshielded portion of the photoresist and to etch through to the upper surface of the substrate 10 .
[0061] S30, setting a source S, a drain D and a gate G, specifically including the following sub-steps:
[0062] S31, spin-coating photoresist on the entire wafer and etching out the set source region and drain region through ultraviolet lithography process and a photolithography mask of a preset shape, and depositing 10nm thick Cr and 30nm thick Au on the source region, the drain region, the region etched in step S22 and the photoresist through PVD;
[0063] S32, after the deposition is completed, the device is immersed in an acetone solution to remove the photoresist and the Cr / Au covering the photoresist, and the remaining parts are the source S, the drain D and the gate G. (The relevant leads in this embodiment are also prepared in this step).
[0064] S40, setting a sample plate 40, specifically includes the following sub-steps:
[0065] S41, PDMS and coagulant are mixed in a mass ratio of 25:1, stirred evenly, and the mixed solution is placed in a vacuum box to evacuate to remove gas in the mixed solution. After the evacuation is completed, the mixed solution is poured into the prepared mold and heated at 75°C for 1 hour to solidify the PDMS in the mold. When pouring and preparing the sample plate 40, in order to make the surface of the sample plate 40 flat, a layer of glass plate is added to the surface of the mold where the mixed solution is added. After the curing is completed, the PDMS is peeled off from the mold to obtain the sample plate 40 with the sample groove 40a.
[0066] S42, due to the good transparency and adhesion of PDMS, the sample plate 40 with the sample groove 40a is placed on the dielectric layer 20 and the electrode processed in step S22 by the adhesion of PDMS under naked eye observation. In this step, the sample groove 40a needs to be aligned with the channel layer 31.
[0067] S50, set antibody 50, as follows Figure 5 As shown, Figure 5 Schematic diagram of a biofunctionalization process of a 2×3 transistor array device based on an IGZO thin film according to an embodiment of the present invention, wherein step S50 includes the following sub-steps:
[0068] S51, pouring a 1% APTES ethanol solution into the sample slot 40a and completely covering the channel layer 31 in the sample slot 40a area, incubating at room temperature for 1 hour, and then washing away the unbound APTES with ethanol. In this step, APTES is covalently bound to the IGZO surface through the oxygen-containing groups on the IGZO surface, so that the surface is amino-modified;
[0069] S52, after baking the device processed in step S51 at 100°C for 30 minutes, add 2.5% GA solution to the sample tank 40a and incubate at room temperature for 1 hour, then use 0.1mmol / L PBS to wash away the unbound GA. In this step, GA activates the amino group in step S51, and the aldehyde group at one end of GA is combined with the amino group of APTES, and the aldehyde group at the other end is exposed to the outside;
[0070] S53, add β2-MG antibody to the three sample grooves on the left, add CysC antibody to the three sample grooves on the right, place the device in a 4°C refrigerator and incubate for more than 12 hours, then use PBS to wash away the unbound β2-MG antibody and CysC antibody. In this step, the amino groups of β2-MG antibody and CysC antibody are respectively bound to the aldehyde groups exposed to the outside of GA in the corresponding sample grooves, thereby firmly binding to the surface of IGZO (i.e., channel layer 31).
[0071] <Test example>
[0072] This test example performs corresponding tests on the IGZO film-based 2×3 transistor array device 100 in the embodiment, and provides an application of the IGZO film-based 2×3 transistor array device in the simultaneous high-throughput specific sensitive detection of microliter-level β2-MG antigen protein and CysC antigen protein.
[0073] Figure 6 is a SEM characterization image of a partial cross section of a 2×3 transistor array device based on an IGZO thin film according to a test example of the present invention; Figure 7is an optical microscope image of a partial cross section of a 2×3 transistor array device based on an IGZO thin film according to a test example of the present invention; Figure 8 This is an AFM characterization image of a partial cross section of a 2×3 transistor array device based on an IGZO thin film according to a test example of the present invention.
[0074] like Figures 6 to 8 As shown, the 2×3 transistor array device 100 based on IGZO thin film in this test example is successfully prepared by micro-nano process, wherein the thickness of the dielectric layer 20 is about 30nm, the thickness of the channel layer 31 is about 30nm, and the source S, drain D and gate G are all Cr with a thickness of about 10nm and Au with a thickness of about 30nm layer by layer.
[0075] Fig. 9 is a transfer characteristic curve of a 2×3 transistor array device based on an IGZO thin film according to a test example of the present invention; Fig.10 This is a transfer characteristic curve of a 2×3 transistor array device based on an IGZO thin film, which is a test example of the present invention, when the dielectric layer material is replaced from Al2O3 to SiO2.
[0076] like Fig. 9 and 10 As shown, the 2×3 transistor array device 100 based on IGZO film in this test example uses Al2O3 film as the dielectric layer. Compared with the traditional IGZO-based transistor device prepared with SiO2 as the dielectric layer, the device prepared by this dielectric layer has a lower threshold voltage and a higher electron mobility, which can significantly improve the performance of the transistor.
[0077] Fig.11 This is a test example of the present invention for detecting the performance consistency of antibodies bound to and at 6 channel layers in a single transistor array in a 2×3 transistor array device based on an IGZO film.
[0078] like Fig.11 As shown, in this test example, a single transistor array of the 2×3 transistor array device 100 based on IGZO thin film contains 2×3 transistors composed of source and drain electrodes and corresponding channel layers, which has good consistency, avoiding the performance error caused by the process preparation process in the preparation of a single device, making the detection effect more accurate. The array device can realize the simultaneous detection of β2-MG protein and CysC protein, with low detection cost, and has broad application prospects in high-throughput sensitive detection of disease markers. The two columns are detected simultaneously, and the error of the detection results is smaller, which further improves the detection accuracy. At the same time, it overcomes the defects of traditional detection methods that require large equipment, low detection accuracy and long cycle, realizes the rapid and accurate detection of disease markers, and improves the detection portability of the device.
[0079] Fig.12 This is a biosensor performance test diagram of a 2×3 transistor array device based on an IGZO thin film according to a test example of the present invention.
[0080] Among them, (a) is the detection performance of the device for β2-MG samples with different concentrations;
[0081] (b) Detection performance of the device for CysC samples with different concentrations;
[0082] (c) is the fitting curve of the common logarithm and the drain current change rate of β2-MG samples with different concentrations;
[0083] (d) is the fitting curve of the common logarithm and drain current change rate of CysC samples with different concentrations.
[0084] Fig.13 It is a detection specificity test diagram of a 2×3 transistor array device based on an IGZO thin film according to a test example of the present invention.
[0085] Wherein, (a) is the electrical response of the device when the test sample does not contain β2-MG and CysC proteins;
[0086] (b) The electrical response of the device when the test sample contains CysC protein (4 μg / mL) but does not contain β2-MG protein;
[0087] (c) The electrical response of the device when the test sample contained β2-MG protein (12 μg / mL) but did not contain CysC protein;
[0088] (d) is the electrical response of the device when the test sample contains both β2-MG protein (12 μg / mL) and CysC protein (4 μg / mL).
[0089] like Fig.12 and 13 As shown, the 2×3 transistor array device 100 based on the IGZO thin film in this test example achieves 1.2×10 -5 β2-MG protein in the range of μg / mL to 12μg / mL and 4×10 -6 Specific and sensitive detection of CysC protein in the range of μg / mL to 4μg / mL, and the detection range covers the clinical reference range of β2-MG protein and CysC protein.
[0090] Those skilled in the art should understand that the present invention is not limited to the above embodiments, and the above embodiments and descriptions are only for explaining the principles of the present invention. Without departing from the spirit and scope of the present invention, the present invention may have various changes and improvements, and these changes and improvements fall within the scope of the present invention to be protected. The scope of protection of the present invention is defined by the attached claims and their equivalents.
Claims
1. A 2×3 transistor array device based on IGZO thin film, It is characterized in that For simultaneous detection of β2-MG and CysC, including: substrate; The dielectric layer is provided on the substrate and is made of Al 2 O 3 ; At least one transistor array, the transistor array comprising: The number of 6 IGZO channel layers is distributed on the dielectric layer and does not contact each other. Source electrodes and drain electrodes, 6 pairs in total, the source electrodes and drain electrodes are arranged in pairs on the dielectric layer and are indirectly connected through the corresponding channel layer, and A gate, disposed on the substrate and in contact with the dielectric layer; A sample plate, disposed on the dielectric layer and the transistor array, the sample plate being provided with a plurality of sample grooves with openings facing upward, the sample grooves corresponding to the channel layers one by one and connected to the surface of the channel layer; and β2-MG antibody and CysC antibody are bound to the channel layer and located in the sample groove, Wherein, in a single transistor array, at least one of the channel layers is bound to the β2-MG antibody, and at least one of the channel layers is bound to the CysC antibody. The detection limits of the 2×3 transistor array device based on IGZO thin film for β2-MG antigen protein and CysC antigen protein were 1.2×10 -5 μg / mL and 4.0×10 -6 μg / mL.
2. The 2×3 transistor array device based on IGZO thin film according to claim 1, characterized in that: in, In a single transistor array, three of the channel layers are bound to the β2-MG antibody, and another three of the channel layers are bound to the CysC antibody.
3. The 2×3 transistor array device based on IGZO thin film according to claim 1, characterized in that: in, The material of the substrate includes p ++ -Si, The source electrode, the drain electrode or the gate electrode is made of Cr and / or Au. The material of the sample plate includes transparent PDMS.
4. The 2×3 transistor array device based on IGZO thin film according to claim 1, characterized in that: in, The source electrode and the drain electrode are both connected to the channel layer through leads of an integrally formed design.
5. A method for preparing a 2×3 transistor array device based on IGZO thin film, It is characterized in that The method for preparing a 2×3 transistor array device based on an IGZO thin film according to any one of claims 1 to 4 comprises the following steps: S10, deposit a layer of Al on a clean substrate 2 O 3 A thin film is used as a dielectric layer, and then a layer of IGZO thin film is deposited at several different positions on the dielectric layer as a channel layer; S20, etching a portion of the dielectric layer in a preset area to reach the substrate surface; S30, depositing source electrodes and drain electrodes corresponding to the plurality of channel layers on the dielectric layer, and depositing gate electrodes in the regions etched in step S20; S40, placing a sample plate with sample grooves on the dielectric layer on which the source electrode and the drain electrode are deposited, and making the sample grooves correspond to the channel layer one by one; S50, respectively binding β2-MG antibody and CysC antibody to the channel layers in several different sample grooves through APTES-GA.
6. The method for preparing a 2×3 transistor array device based on an IGZO thin film according to claim 5 , Features: Wherein, step S10 includes the following sub-steps: S11, a layer of Al is prepared on the surface of a clean substrate by atomic energy deposition. 2 O 3 The film is used as a dielectric layer; S12, depositing a layer of IGZO thin film on the surface of the dielectric layer by magnetron sputtering, then spin-coating a photoresist on a set area of the thin film and performing ultraviolet exposure, development and fixing to achieve patterning of the IGZO; S13, using an acid solution to wet-etch the IGZO film on the portion where the photoresist is not spin-coated, and the remaining portion is a plurality of channel layers.
7. The method for preparing a 2×3 transistor array device based on an IGZO thin film according to claim 5, characterized in that: in, Step S20 includes the following sub-steps: S21, spin-coating photoresist on a part of the set area of the dielectric layer and the channel layer and etching a set gate area by ultraviolet lithography; S22, using a mixture of monohydrated ammonia, hydrogen peroxide and water as an etching solution to etch away the Al corresponding to the set gate area. 2 O 3 The film extends to the upper surface of the substrate.
8. The method for preparing a 2×3 transistor array device based on an IGZO thin film according to claim 5 , Features: Wherein, step S30 includes the following sub-steps: S31, spin-coating photoresist on the dielectric layer and the channel layer and etching out a set source region and a drain region by ultraviolet lithography, and depositing Cr and / or Au on the source region, the drain region, the region etched in step S20 and the photoresist by PVD; S32, stripping the photoresist and Cr and / or Au covering the photoresist in an acetone solution, and the remaining parts are the source electrode, the drain electrode and the gate electrode.
9. The method for preparing a 2×3 transistor array device based on an IGZO thin film according to claim 5, characterized in that: in, Step S40 includes the following sub-steps: S41, mixing PDMS and a coagulant, casting the mixture into a mold of a set shape, and heating and curing the mixture to obtain the sample plate, S42, placing the sample plate on the medium layer processed in step S30 through the adhesion of PDMS; Step S50 includes the following sub-steps: S51, pouring a 1% APTES ethanol solution into a plurality of the sample slots to completely cover the channel layer in the sample slot area, incubating for a certain period of time, and then washing away the unbound APTES with ethanol. S52, after heating the device treated in step S51, adding 2.5% GA solution to the sample tank and incubating for a certain period of time, then washing away the unbound GA with PBS, S53, adding β2-MG antibody and CysC antibody to the corresponding sample wells respectively and incubating for a certain period of time, and then washing away the unbound β2-MG antibody and CysC antibody with PBS.
10. Use of the IGZO thin film-based 2×3 transistor array device according to any one of claims 1 to 4 in simultaneous high-throughput specific sensitive detection of microliter-level β2-MG antigen protein and CysC antigen protein.
